Clinical Trials Insight: 700005581
Latest Information Update: 21 Oct 2005
At a glance
- Drugs Raseglurant (Primary)
- Indications Anxiety disorders; Migraine
- Focus Adverse reactions; Pharmacokinetics
- 21 Oct 2005 New trial record.
Latest Information Update: 21 Oct 2005